GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 711 filers reported holding GLAXOSMITHKLINE PLC in Q3 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,068,000 | -70.4% | 24,764 | -70.2% | 2.44% | -12.0% |
| Q2 2016 | $3,606,000 | -7.7% | 83,213 | -13.6% | 2.77% | +9.6% |
| Q1 2016 | $3,906,000 | -3.0% | 96,328 | -3.5% | 2.52% | +5.3% |
| Q4 2015 | $4,026,000 | -2.9% | 99,778 | -7.5% | 2.40% | -1.9% |
| Q3 2015 | $4,147,000 | -11.9% | 107,863 | -4.6% | 2.44% | +1.0% |
| Q2 2015 | $4,709,000 | -7.9% | 113,071 | +2.1% | 2.42% | -11.5% |
| Q1 2015 | $5,111,000 | -12.5% | 110,742 | -19.0% | 2.73% | +3.6% |
| Q4 2014 | $5,840,000 | -16.3% | 136,646 | -9.9% | 2.64% | -2.0% |
| Q3 2014 | $6,974,000 | -18.0% | 151,701 | -4.6% | 2.69% | -9.4% |
| Q2 2014 | $8,501,000 | +1.6% | 158,948 | +1.5% | 2.97% | -2.1% |
| Q1 2014 | $8,365,000 | -1.7% | 156,559 | -1.7% | 3.03% | -0.6% |
| Q4 2013 | $8,506,000 | +5.9% | 159,318 | -0.5% | 3.05% | -1.1% |
| Q3 2013 | $8,033,000 | -4.3% | 160,121 | -4.7% | 3.08% | -5.4% |
| Q2 2013 | $8,394,000 | – | 167,981 | – | 3.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |